Alzamend Neuro Inc

Research Alzamend Neuro Inc (ALZN) on Bullrun: market cap USD 4.41M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALZN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 4.41M
• Financial periodFY2025
• Net income-USD 4.51M

Valuation Snapshot

latest market cap is USD 4.41M.

About Alzamend Neuro Inc

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders;

Frequently asked questions

What is Alzamend Neuro Inc's market cap?

Alzamend Neuro Inc's market capitalization is USD 4.41M.

What does Alzamend Neuro Inc do?

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.